Literature DB >> 12769848

Crystal structure of a tetradecameric assembly of the association domain of Ca2+/calmodulin-dependent kinase II.

André Hoelz1, Angus C Nairn, John Kuriyan.   

Abstract

We report the crystal structure of the 143 residue association domain of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII). The association domain forms a hub-like assembly, composed of two rings of seven protomers each, which are stacked head to head and held together by extensive interfaces. The tetradecameric organization of the assembly was confirmed by analytical ultracentrifugation and multiangle light scattering. Individual protomers form wedge-shaped structures from which N-terminal helical segments that connect to the kinase domain extend toward the equatorial plane of the assembly, consistent with the arrangement of the kinase domains in a second outer ring. A deep and highly conserved pocket present within the association domain may serve as a docking site for proteins that interact with CaMKII.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12769848     DOI: 10.1016/s1097-2765(03)00171-0

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  81 in total

1.  Crystal structure of alpha-COP in complex with epsilon-COP provides insight into the architecture of the COPI vesicular coat.

Authors:  Kuo-Chiang Hsia; André Hoelz
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-03       Impact factor: 11.205

2.  Structural and functional analysis of an essential nucleoporin heterotrimer on the cytoplasmic face of the nuclear pore complex.

Authors:  Kimihisa Yoshida; Hyuk-Soo Seo; Erik W Debler; Günter Blobel; André Hoelz
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

3.  Covert Changes in CaMKII Holoenzyme Structure Identified for Activation and Subsequent Interactions.

Authors:  Tuan A Nguyen; Pabak Sarkar; Jithesh V Veetil; Kaitlin A Davis; Henry L Puhl; Steven S Vogel
Journal:  Biophys J       Date:  2015-05-05       Impact factor: 4.033

4.  Normal modes for predicting protein motions: a comprehensive database assessment and associated Web tool.

Authors:  Vadim Alexandrov; Ursula Lehnert; Nathaniel Echols; Duncan Milburn; Donald Engelman; Mark Gerstein
Journal:  Protein Sci       Date:  2005-03       Impact factor: 6.725

5.  Structures of two core subunits of the bacterial type IV secretion system, VirB8 from Brucella suis and ComB10 from Helicobacter pylori.

Authors:  Laurent Terradot; Richard Bayliss; Clasien Oomen; Gordon A Leonard; Christian Baron; Gabriel Waksman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-11       Impact factor: 11.205

6.  CaMKIIbeta association with the actin cytoskeleton is regulated by alternative splicing.

Authors:  Heather O'Leary; Erika Lasda; K Ulrich Bayer
Journal:  Mol Biol Cell       Date:  2006-08-23       Impact factor: 4.138

Review 7.  Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.

Authors:  Vladimir N Uversky; Alexander V Kabanov; Yuri L Lyubchenko
Journal:  J Proteome Res       Date:  2006-10       Impact factor: 4.466

8.  Mass of the postsynaptic density and enumeration of three key molecules.

Authors:  Xiaobing Chen; Lucia Vinade; Richard D Leapman; Jennifer D Petersen; Terunaga Nakagawa; Terry M Phillips; Morgan Sheng; Thomas S Reese
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

9.  Ca2+-independent activation of Ca2+/calmodulin-dependent protein kinase II bound to the C-terminal domain of CaV2.1 calcium channels.

Authors:  Venkat G Magupalli; Sumiko Mochida; Jin Yan; Xin Jiang; Ruth E Westenbroek; Angus C Nairn; Todd Scheuer; William A Catterall
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

Review 10.  Negative regulation of multifunctional Ca2+/calmodulin-dependent protein kinases: physiological and pharmacological significance of protein phosphatases.

Authors:  A Ishida; N Sueyoshi; Y Shigeri; I Kameshita
Journal:  Br J Pharmacol       Date:  2008-05-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.